Localized prostate cancer presenting as a renal pseudo-tumour

Por Poonja, Zia, So, Alan, Eigl, Bernhard J
Publicado no Can Urol Assoc J (2015)

Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system?

Por Jones, Britney, Syme, Rachel, Eliasziw, Misha, Eigl, Bernhard J.
Publicado em 2013

Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen

Por Blumenstein, Brent, Saad, Fred, Hotte, Sebastien, Chi, Kim N, Eigl, Bernhard, Gleave, Martin, Jacobs, Cindy
Publicado em 2013

Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline

Por Miles, Brendan J.W., Fairey, Adrian S., Eliasziw, Michael, Estey, Eric P., Venner, Peter, Finch, Daygen, Trpkov, Kiril, Eigl, Bernhard J.
Publicado em 2010

A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer

Por Clayton, Ravinder, Wu, Jackson, Heng, Daniel Y., North, Scott A., Emmenegger, Urban, Hotte, Sebastien, Chi, Kim, Zielinski, Rob, Al-Shamsi, Humaid, Chen, Leo, Eigl, Bernhard
Publicado em 2014

Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists

Por Hsu, Tina, Black, Peter C., Chi, Kim N., Canil, Christina M., Eigl, Bernhard J., Kulkarni, Girish, North, Scott, Wood, Lori, Zlotta, Alexandre R., Lau, Anthea, Panzarella, Tony, Sridhar, Srikala S.
Publicado em 2014

Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Por Necchi, Andrea, Pond, Gregory R., Giannatempo, Patrizia, Di Lorenzo, Giuseppe, Eigl, Bernhard J., Locke, Jenn, Pal, Sumanta K., Agarwal, Neeraj, Poole, Austin, Vaishampayan, Ulka N., Niegisch, Guenter, Hussain, Syed A., Singh, Parminder, Bellmunt, Joaquim, Sonpavde, Guru
Publicado no Clin Genitourin Cancer (2014)

Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study

Por Buonerba, Carlo, Di Lorenzo, Giuseppe, Pond, Gregory, Cartenì, Giacomo, Scagliarini, Sarah, Rozzi, Antonio, Quevedo, Fernando J., Dorff, Tanya, Nappi, Lucia, Lanzetta, Gaetano, Pagliaro, Lance, Eigl, Bernhard J., Naik, Gurudatta, Ferro, Matteo, Galdiero, Mariano, De Placido, Sabino, Sonpavde, Guru
Publicado no Front Pharmacol (2016)